thiazoles has been researched along with Hypertrophy, Left Ventricular in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, ML; Frossard, N; Gassmann, M; Nemska, S; Tavakoli, R | 1 |
| Anker, S; Balligand, JL; Brito, D; Brosteanu, O; Casadei, B; Edelmann, F; Filippatos, G; Gerber, BL; Gruson, D; Hasenclever, D; Ikonomidis, I; Lhommel, R; Mahmod, M; Neubauer, S; Persu, A; Piechnik, S; Pieske, B; Pieske-Kraigher, E; Pinto, F; Ponikowski, P; Pouleur, AC; Senni, M; Trochu, JN; Van Overstraeten, N; Wachter, R | 1 |
| Antman, EM; Braunwald, E; Corbalán, R; Dalby, A; Dorobantu, M; Eisen, A; Giugliano, RP; Lanz, H; Mercuri, M; Nordio, F; Ruff, CT; Rutman, H; Wiviott, SD | 1 |
| Bache, RJ; Chen, Y; Hu, X; Lu, Z; Wessale, JL; Xu, X; Zhang, P; Zhao, L | 1 |
| Bache, R; Chen, Y; Hu, X; Wessale, J; Xu, X; Zhang, P; Zhao, L | 1 |
| Schmidt, BM; Wagner, AD | 1 |
| Burns, WC; Burrell, LM; Candido, R; Cooper, ME; Dean, RG; Forbes, JM; Ritchie, RH; Thallas, V; Thomas, MC; Tikellis, C; Twigg, SM | 1 |
| Fedak, PW; Liu, PP; Verma, S; Wang, CH; Weisel, RD | 1 |
| Kass, DA | 1 |
| Foiles, P; Founds, H; Vasan, S | 1 |
| Abe, N; Hirayama, H; Makino, N; Sugano, M; Yonemoch, H | 1 |
2 review(s) available for thiazoles and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
[Hyperuricemia, gout, pseudogout and concomitant diseases].
Topics: Allopurinol; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chondrocalcinosis; Comorbidity; Diabetes Mellitus, Type 2; Febuxostat; Gout; Gout Suppressants; Guideline Adherence; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Interleukin 1 Receptor Antagonist Protein; Kidney Failure, Chronic; Thiazoles; Xanthine Oxidase | 2011 |
Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
Topics: Aging; Animals; Clinical Trials as Topic; Cross-Linking Reagents; Diabetes Mellitus; Diastole; Drug Evaluation, Preclinical; Elasticity; Glycation End Products, Advanced; Guanidines; Humans; Hypertrophy, Left Ventricular; Molecular Structure; Myocardium; Proteins; Skin; Thiazoles | 2003 |
1 trial(s) available for thiazoles and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Be
Topics: Acetanilides; Adolescent; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Diastole; Disease Progression; Double-Blind Method; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Prospective Studies; Stroke Volume; Thiazoles; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2018 |
8 other study(ies) available for thiazoles and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Chemokine CX3CL1; Collagen Type I, alpha 1 Chain; Constriction; CX3C Chemokine Receptor 1; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyrimidines; Signal Transduction; Thiazoles; Time Factors; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Cardiotonic Agents; Death, Sudden, Cardiac; Digitalis Glycosides; Factor Xa Inhibitors; Female; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Proportional Hazards Models; Protective Factors; Pyridines; Risk Factors; Stroke Volume; Thiazoles | 2016 |
Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice.
Topics: Animals; Disease Models, Animal; Febuxostat; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Systole; Thiazoles; Ventricular Dysfunction, Left | 2008 |
Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction.
Topics: Allopurinol; Animals; Constriction, Pathologic; Enzyme Inhibitors; Febuxostat; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Thiazoles; Xanthine Oxidase | 2010 |
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
Topics: Animals; Blood Pressure; Body Weight; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2003 |
Glitazones and heart failure: critical appraisal for the clinician.
Topics: Contraindications; Heart; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Metabolic Syndrome; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neurotransmitter Agents; Thiazoles; Vascular Resistance | 2003 |
Getting better without AGE: new insights into the diabetic heart.
Topics: Animals; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Natriuretic Peptide, Brain; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2003 |
Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients.
Topics: Blood Flow Velocity; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chromans; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Insulin; Middle Aged; Myocardial Contraction; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |